High-grade serous peritoneal cancer follows a high stromal response signature and shows worse outcome than ovarian cancer.

Considering that the clinical outcome could depend on site as previously suggested based on cell surface glycan signatures using mass spectrometry [ 23 ], tumors collected from the peritoneum showed a trend toward earlier relapse (Figure 2D ) and earlier time of death from disease (chi‐square 9.2, P < 0.01, Figure 2E ).

also in 53,322 other papers